Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:1015-1022
Published online before print April 29, 2004, doi: 10.1161/01.ATV.0000130465.23430.74
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
24/6/1015    most recent
01.ATV.0000130465.23430.74v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mackman, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mackman, N.
Related Collections
Right arrow Coagulation
Right arrow Animal models of human disease
Right arrow Genetically altered mice
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:1015.)
© 2004 American Heart Association, Inc.


Brief Reviews

Role of Tissue Factor in Hemostasis, Thrombosis, and Vascular Development

Nigel Mackman

From The Scripps Research Institute, Departments of Immunology & Cell Biology, La Jolla, Calif.

Correspondence to Dr Nigel Mackman, The Scripps Research Institute, Departments of Immunology & Cell Biology, 10550 North Torrey Pines Road, La Jolla, CA 92037. E-mail nmackman{at}scripps.edu

Tissue factor (TF) is best known as the primary cellular initiator of blood coagulation. After vessel injury, the TF:FVIIa complex activates the coagulation protease cascade, which leads to fibrin deposition and activation of platelets. TF deficiency causes embryonic lethality in the mouse and there have been no reports of TF deficiency in humans. These results indicate that TF is essential for life, most likely because of its central role in hemostasis. In addition, aberrant TF expression within the vasculature initiates life-threatening thrombosis in various diseases, such as sepsis, atherosclerosis, and cancer. Finally, recent studies have revealed a nonhemostatic role of TF in the generation of coagulation proteases and subsequent activation of protease activated receptors (PARs) on vascular cells. This TF-dependent signaling contributes to a variety of biological processes, including inflammation, angiogenesis, metastasis, and cell migration. This review focuses on the roles of TF in hemostasis, thrombosis, and vascular development.

Tissue factor (TF) expression by nonvascular cells plays an essential role in hemostasis by activating blood coagulation. In contrast, TF expression by vascular cells induces intravascular thrombosis. Finally, TF-dependent assembly of coagulation proteases on vascular cells activates protease activated receptors, which contributes to inflammation, angiogenesis, and metastasis.


Key Words: tissue factor • coagulation proteases • PAR signaling




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. G. Dickhout, S. Basseri, and R. C. Austin
Macrophage Function and Its Impact on Atherosclerotic Lesion Composition, Progression, and Stability: The Good, the Bad, and the Ugly
Arterioscler. Thromb. Vasc. Biol., August 1, 2008; 28(8): 1413 - 1415.
[Full Text] [PDF]


Home page
J. Immunol.Home page
L. J. Toltl, S. Beaudin, P. C. Liaw, and and the Canadian Critical Care Translational Biolo
Activated Protein C Up-Regulates IL-10 and Inhibits Tissue Factor in Blood Monocytes
J. Immunol., August 1, 2008; 181(3): 2165 - 2173.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
N. Mackman and M. B. Taubman
Does Tissue Factor Expression by Vascular Smooth Muscle Cells Provide a Link Between C-Reactive Protein and Cardiovascular Disease?
Arterioscler. Thromb. Vasc. Biol., April 1, 2008; 28(4): 601 - 603.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S.K. Payeli, R. Latini, C. Gebhard, A. Patrignani, U. Wagner, T.F. Luscher, and F.C. Tanner
Prothrombotic Gene Expression Profile in Vascular Smooth Muscle Cells of Human Saphenous Vein, but Not Internal Mammary Artery
Arterioscler. Thromb. Vasc. Biol., April 1, 2008; 28(4): 705 - 710.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
F. Szlam, T. Taketomi, C. A. Sheppard, C. L. Kempton, J. H. Levy, and K. A. Tanaka
Antithrombin Affects Hemostatic Response to Recombinant Activated Factor VII in Factor VIII Deficient Plasma
Anesth. Analg., March 1, 2008; 106(3): 719 - 724.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. T.B. Crawley and D. A. Lane
The Haemostatic Role of Tissue Factor Pathway Inhibitor
Arterioscler. Thromb. Vasc. Biol., February 1, 2008; 28(2): 233 - 242.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. Gailani and T. Renne
Intrinsic Pathway of Coagulation and Arterial Thrombosis
Arterioscler. Thromb. Vasc. Biol., December 1, 2007; 27(12): 2507 - 2513.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. Boden, V. R. Vaidyula, C. Homko, P. Cheung, and A. K. Rao
Circulating Tissue Factor Procoagulant Activity and Thrombin Generation in Patients with Type 2 Diabetes: Effects of Insulin and Glucose
J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4352 - 4358.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Wang, S. A. Mahmud, P. B. Bitterman, Y. Huo, and A. Slungaard
Histone Deacetylase Inhibitors Suppress TF-{kappa}B-dependent Agonist-driven Tissue Factor Expression in Endothelial Cells and Monocytes
J. Biol. Chem., September 28, 2007; 282(39): 28408 - 28418.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
M. Ghosh, H. Wang, Y. Ai, E. Romeo, J. P. Luyendyk, J. M. Peters, N. Mackman, S. K. Dey, and T. Hla
COX-2 suppresses tissue factor expression via endocannabinoid-directed PPAR{delta} activation
J. Exp. Med., September 3, 2007; 204(9): 2053 - 2061.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
R. J. White, D. F. Meoli, R. F. Swarthout, D. Y. Kallop, I. I. Galaria, J. L. Harvey, C. M. Miller, B. C. Blaxall, C. M. Hall, R. A. Pierce, et al.
Plexiform-like lesions and increased tissue factor expression in a rat model of severe pulmonary arterial hypertension
Am J Physiol Lung Cell Mol Physiol, September 1, 2007; 293(3): L583 - L590.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. H. Versteeg and W. Ruf
Tissue Factor Coagulant Function Is Enhanced by Protein-disulfide Isomerase Independent of Oxidoreductase Activity
J. Biol. Chem., August 31, 2007; 282(35): 25416 - 25424.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
O. Panes, V. Matus, C. G. Saez, T. Quiroga, J. Pereira, and D. Mezzano
Human platelets synthesize and express functional tissue factor
Blood, June 15, 2007; 109(12): 5242 - 5250.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
G. Boden, V. Vaidyula, C. Homko, M. Mozzoli, and A. K. Rao
Differential effects of somatostatin on circulating tissue factor procoagulant activity and protein
Am J Physiol Endocrinol Metab, May 1, 2007; 292(5): E1333 - E1339.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Cai, C. Song, I. Endoh, J. Goyette, W. Jessup, S. B. Freedman, H. P. McNeil, and C. L. Geczy
Serum Amyloid A Induces Monocyte Tissue Factor
J. Immunol., February 1, 2007; 178(3): 1852 - 1860.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J.-G. Wang, S. A. Mahmud, J. Nguyen, and A. Slungaard
Thiocyanate-Dependent Induction of Endothelial Cell Adhesion Molecule Expression by Phagocyte Peroxidases: A Novel HOSCN-Specific Oxidant Mechanism to Amplify Inflammation
J. Immunol., December 15, 2006; 177(12): 8714 - 8722.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
H. Schwertz, N. D. Tolley, J. M. Foulks, M. M. Denis, B. W. Risenmay, M. Buerke, R. E. Tilley, M. T. Rondina, E. M. Harris, L. W. Kraiss, et al.
Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenecity of human platelets
J. Exp. Med., October 30, 2006; 203(11): 2433 - 2440.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. G. Camici, J. Steffel, A. Akhmedov, N. Schafer, J. Baldinger, U. Schulz, K. Shojaati, C. M. Matter, Z. Yang, T. F. Luscher, et al.
Dimethyl Sulfoxide Inhibits Tissue Factor Expression, Thrombus Formation, and Vascular Smooth Muscle Cell Activation: A Potential Treatment Strategy for Drug-Eluting Stents
Circulation, October 3, 2006; 114(14): 1512 - 1521.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Ahamed, H. H. Versteeg, M. Kerver, V. M. Chen, B. M. Mueller, P. J. Hogg, and W. Ruf
Disulfide isomerization switches tissue factor from coagulation to cell signaling
PNAS, September 19, 2006; 103(38): 13932 - 13937.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
T. Shoji, H. Koyama, T. Morioka, S. Tanaka, A. Kizu, K. Motoyama, K. Mori, S. Fukumoto, A. Shioi, N. Shimogaito, et al.
Receptor for advanced glycation end products is involved in impaired angiogenic response in diabetes.
Diabetes, August 1, 2006; 55(8): 2245 - 2255.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
B. E. Stahli, G. G. Camici, J. Steffel, A. Akhmedov, K. Shojaati, M. Graber, T. F. Luscher, and F. C. Tanner
Paclitaxel Enhances Thrombin-Induced Endothelial Tissue Factor Expression via c-Jun Terminal NH2 Kinase Activation
Circ. Res., July 21, 2006; 99(2): 149 - 155.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
G. Stoll and M. Bendszus
Inflammation and Atherosclerosis: Novel Insights Into Plaque Formation and Destabilization
Stroke, July 1, 2006; 37(7): 1923 - 1932.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. Uzonyi, K. Lotzer, S. Jahn, C. Kramer, M. Hildner, E. Bretschneider, D. Radke, M. Beer, R. Vollandt, J. F. Evans, et al.
Cysteinyl leukotriene 2 receptor and protease-activated receptor 1 activate strongly correlated early genes in human endothelial cells
PNAS, April 18, 2006; 103(16): 6326 - 6331.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. N. Athanasopoulos, M. Economopoulou, V. V. Orlova, A. Sobke, D. Schneider, H. Weber, H. G. Augustin, S. A. Eming, U. Schubert, T. Linn, et al.
The extracellular adherence protein (Eap) of Staphylococcus aureus inhibits wound healing by interfering with host defense and repair mechanisms
Blood, April 1, 2006; 107(7): 2720 - 2727.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
C. Kleinschnitz, G. Stoll, M. Bendszus, K. Schuh, H.-U. Pauer, P. Burfeind, C. Renne, D. Gailani, B. Nieswandt, and T. Renne
Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis
J. Exp. Med., March 20, 2006; 203(3): 513 - 518.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
R. W. Colman
Are hemostasis and thrombosis two sides of the same coin?
J. Exp. Med., March 20, 2006; 203(3): 493 - 495.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. E. Tilley, B. Pedersen, R. Pawlinski, Y. Sato, J. H. Erlich, Y. Shen, S. Day, Y. Huang, D. T. Eitzman, W. A. Boisvert, et al.
Atherosclerosis in Mice Is Not Affected by a Reduction in Tissue Factor Expression
Arterioscler. Thromb. Vasc. Biol., March 1, 2006; 26(3): 555 - 562.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J.-G. Wang, S. A. Mahmud, J. A. Thompson, J.-G. Geng, N. S. Key, and A. Slungaard
The principal eosinophil peroxidase product, HOSCN, is a uniquely potent phagocyte oxidant inducer of endothelial cell tissue factor activity: a potential mechanism for thrombosis in eosinophilic inflammatory states
Blood, January 15, 2006; 107(2): 558 - 565.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
V. R. Vaidyula, A. K. Rao, M. Mozzoli, C. Homko, P. Cheung, and G. Boden
Effects of Hyperglycemia and Hyperinsulinemia on Circulating Tissue Factor Procoagulant Activity and Platelet CD40 Ligand
Diabetes, January 1, 2006; 55(1): 202 - 208.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
A. Parolari, L. Mussoni, M. Frigerio, M. Naliato, F. Alamanni, G. L. Polvani, M. Agrifoglio, F. Veglia, E. Tremoli, P. Biglioli, et al.
The role of tissue factor and P-selectin in the procoagulant response that occurs in the first month after on-pump and off-pump coronary artery bypass grafting
J. Thorac. Cardiovasc. Surg., December 1, 2005; 130(6): 1561 - 1566.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
N. Mackman
Tissue-Specific Hemostasis in Mice
Arterioscler. Thromb. Vasc. Biol., November 1, 2005; 25(11): 2273 - 2281.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
T. Renne, M. Pozgajova, S. Gruner, K. Schuh, H.-U. Pauer, P. Burfeind, D. Gailani, and B. Nieswandt
Defective thrombus formation in mice lacking coagulation factor XII
J. Exp. Med., July 18, 2005; 202(2): 271 - 281.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Pedersen, T. Holscher, Y. Sato, R. Pawlinski, and N. Mackman
A balance between tissue factor and tissue factor pathway inhibitor is required for embryonic development and hemostasis in adult mice
Blood, April 1, 2005; 105(7): 2777 - 2782.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
B. Hugel, M. C. Martinez, C. Kunzelmann, and J.-M. Freyssinet
Membrane Microparticles: Two Sides of the Coin
Physiology, February 1, 2005; 20(1): 22 - 27.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. V. M. Rao and U. R. Pendurthi
Tissue Factor-Factor VIIa Signaling
Arterioscler. Thromb. Vasc. Biol., January 1, 2005; 25(1): 47 - 56.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. M. Day, J. L. Reeve, B. Pedersen, D. M Farris, D. D. Myers, M. Im, T. W. Wakefield, N. Mackman, and W. P. Fay
Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall
Blood, January 1, 2005; 105(1): 192 - 198.
[Abstract] [Full Text] [PDF]